Literature DB >> 18680199

Attenuated apoptosis response to Fas-ligand in active ulcerative colitis.

Jakob B Seidelin1, Ole H Nielsen.   

Abstract

BACKGROUND: From mainly carcinoma cell line studies, apoptosis has been thought to play a major role in the pathogenesis of ulcerative colitis (UC). Apoptosis has been suggested to be due to a Fas ligand / Fas receptor interaction, but has never been studied in cells from patients with active UC. The aim was to investigate both the spontaneous and the cell death receptor ligand-induced apoptosis in UC.
METHODS: Twenty patients with UC and 16 control subjects who underwent routine colonoscopy either for the control or surveillance of their disease or where the diagnosis of irritable bowel syndrome was subsequently reached were included. Cultures of isolated colonic crypts were obtained from biopsies and cultured for 4 to 16 hours with Fas ligand or Fas ligand and costimulation with interferon-gamma (IFN-gamma). Control experiments were performed on HT29 cells. Apoptosis was assessed by independent methods.
RESULTS: Isolated colonocytes from healthy subjects or patients with remission in UC had a dose-dependent response to Fas ligand. This response was abolished in patients with active UC (P < 0.002), and costimulation with IFN-gamma did not alter this response. Patients with active UC had an increased apoptosis rate of 9.5% compared with controls (P < 0.05).
CONCLUSIONS: The current study indicates that colonocytes do not respond to cytokine exposure and inflammation by an increased vulnerability, as previously thought. Colonocytes seem to activate cytoprotective programs in response to inflammation. Apart from supporting the regeneration process during inflammation, this response could additionally cause an increased susceptibility to neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680199     DOI: 10.1002/ibd.20629

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

1.  Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.

Authors:  Xiaohong Wang; Dan Li; Yong Zhang; Shuang Wu; Fang Tang
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

2.  ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis.

Authors:  Jakob Benedict Seidelin; Mehmet Coskun; Ben Vainer; Lene Riis; Christoffer Soendergaard; Ole Haagen Nielsen
Journal:  J Mol Med (Berl)       Date:  2013-02-01       Impact factor: 4.599

3.  Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis.

Authors:  Xin Liu; Jian Ming Wang
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

4.  Si Shen Wan Regulates Phospholipase Cγ-1 and PI3K/Akt Signal in Colonic Mucosa from Rats with Colitis.

Authors:  Duan-Yong Liu; Rong Xu; Min-Fang Huang; Hong-Yan Huang; Xin Wang; Yong Zou; Hai-Yang Yue; Hai-Mei Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-27       Impact factor: 2.629

Review 5.  Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.

Authors:  Tomasz J Ślebioda; Zbigniew Kmieć
Journal:  Mediators Inflamm       Date:  2014-06-17       Impact factor: 4.711

Review 6.  Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases.

Authors:  Piotr Eder; Liliana Lykowska-Szuber; Kamila Stawczyk-Eder; Iwona Krela-Kaźmierczak; Krzysztof Linke
Journal:  Prz Gastroenterol       Date:  2014-10-19

7.  Differential genetic and functional background in inflammatory bowel disease phenotypes of a Greek population: a systems bioinformatics approach.

Authors:  Maria Gazouli; Nikolas Dovrolis; Andre Franke; George M Spyrou; Leonardo A Sechi; George Kolios
Journal:  Gut Pathog       Date:  2019-06-15       Impact factor: 4.181

8.  Polydeoxyribonucleotide Exerts Therapeutic Effect by Increasing VEGF and Inhibiting Inflammatory Cytokines in Ischemic Colitis Rats.

Authors:  Sung-Eun Kim; Il-Gyu Ko; Jun-Jang Jin; Lakkyong Hwang; Chang-Ju Kim; Sang-Hoon Kim; Jin-Hee Han; Jung Won Jeon
Journal:  Biomed Res Int       Date:  2020-02-21       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.